Edrophonium Alternatives Compared
| Edrophonium | Pyridostigmine | Sugammadex |
|
|---|
| Edrophonium | Pyridostigmine | Sugammadex |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Reversal of Nondepolarizing Muscle Relaxants. edrophonium may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Myasthenia Gravis, Dysautonomia, Reversal of Nondepolarizing Muscle Relaxants, Nerve Agent Pretreatment. pyridostigmine may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Reversal of Neuromuscular Blockade, Reversal of Nondepolarizing Muscle Relaxants. sugammadex may also be used for purposes not listed in this medication guide. |
Related suggestions Reversal of Nondepolarizing Muscle Relaxants
|
|||||||
| More about Edrophonium | More about Pyridostigmine | More about Sugammadex | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Pyridostigmine has an average rating of 7.0 out of 10 from a total of 57 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 20% reported a negative effect. |
Sugammadex has an average rating of 5.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
|
See also: edrophonium side effects in more detail. |
See also: pyridostigmine side effects in more detail. |
See also: sugammadex side effects in more detail. |
||||||||
| Generic Availability | ||||||||||
|
N/A |
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all pyridostigmine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
Mestinon, Mestinon Timespan, Regonol | Bridion | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
1.8 hours |
N/A |
2 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category N
Not classified
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 65 drugs are known to interact with edrophonium:
|
A total of 77 drugs are known to interact with pyridostigmine:
|
A total of 28 drugs are known to interact with sugammadex:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
May 03, 1951 |
April 06, 1955 |
December 15, 2015 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
|
N/A |
||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.